345 related articles for article (PubMed ID: 30383413)
1. Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.
Whittamore JM; Stephens CE; Hatch M
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G82-G94. PubMed ID: 30383413
[TBL] [Abstract][Full Text] [Related]
2. Transcellular oxalate and Cl- absorption in mouse intestine is mediated by the DRA anion exchanger Slc26a3, and DRA deletion decreases urinary oxalate.
Freel RW; Whittamore JM; Hatch M
Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G520-7. PubMed ID: 23886857
[TBL] [Abstract][Full Text] [Related]
3. Urolithiasis and hepatotoxicity are linked to the anion transporter Sat1 in mice.
Dawson PA; Russell CS; Lee S; McLeay SC; van Dongen JM; Cowley DM; Clarke LA; Markovich D
J Clin Invest; 2010 Mar; 120(3):706-12. PubMed ID: 20160351
[TBL] [Abstract][Full Text] [Related]
4. The anion exchanger PAT-1 (Slc26a6) does not participate in oxalate or chloride transport by mouse large intestine.
Whittamore JM; Hatch M
Pflugers Arch; 2021 Jan; 473(1):95-106. PubMed ID: 33205229
[TBL] [Abstract][Full Text] [Related]
5. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.
Hatch M; Gjymishka A; Salido EC; Allison MJ; Freel RW
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G461-9. PubMed ID: 21163900
[TBL] [Abstract][Full Text] [Related]
6. Loss of the anion exchanger DRA (Slc26a3), or PAT1 (Slc26a6), alters sulfate transport by the distal ileum and overall sulfate homeostasis.
Whittamore JM; Hatch M
Am J Physiol Gastrointest Liver Physiol; 2017 Sep; 313(3):G166-G179. PubMed ID: 28526688
[TBL] [Abstract][Full Text] [Related]
7. Essential roles of CFEX-mediated Cl(-)-oxalate exchange in proximal tubule NaCl transport and prevention of urolithiasis.
Aronson PS
Kidney Int; 2006 Oct; 70(7):1207-13. PubMed ID: 16883319
[TBL] [Abstract][Full Text] [Related]
8. Induction of enteric oxalate secretion by Oxalobacter formigenes in mice does not require the presence of either apical oxalate transport proteins Slc26A3 or Slc26A6.
Hatch M
Urolithiasis; 2020 Feb; 48(1):1-8. PubMed ID: 31201468
[TBL] [Abstract][Full Text] [Related]
9. Oxalate: from the environment to kidney stones.
Brzica H; Breljak D; Burckhardt BC; Burckhardt G; Sabolić I
Arh Hig Rada Toksikol; 2013 Dec; 64(4):609-30. PubMed ID: 24384768
[TBL] [Abstract][Full Text] [Related]
10. Role of SLC26A6-mediated Cl⁻-oxalate exchange in renal physiology and pathophysiology.
Aronson PS
J Nephrol; 2010; 23 Suppl 16():S158-64. PubMed ID: 21170874
[TBL] [Abstract][Full Text] [Related]
11. N-glycosylation critically regulates function of oxalate transporter SLC26A6.
Thomson RB; Thomson CL; Aronson PS
Am J Physiol Cell Physiol; 2016 Dec; 311(6):C866-C873. PubMed ID: 27681177
[TBL] [Abstract][Full Text] [Related]
12. Immunolocalization of sat-1 sulfate/oxalate/bicarbonate anion exchanger in the rat kidney.
Karniski LP; Lötscher M; Fucentese M; Hilfiker H; Biber J; Murer H
Am J Physiol; 1998 Jul; 275(1):F79-87. PubMed ID: 9689008
[TBL] [Abstract][Full Text] [Related]
13. Oxalate secretion is stimulated by a cAMP-dependent pathway in the mouse cecum.
Whittamore JM; Hatch M
Pflugers Arch; 2023 Feb; 475(2):249-266. PubMed ID: 36044064
[TBL] [Abstract][Full Text] [Related]
14. In female rats, ethylene glycol treatment elevates protein expression of hepatic and renal oxalate transporter sat-1 (Slc26a1) without inducing hyperoxaluria.
Breljak D; Brzica H; Vrhovac I; Micek V; Karaica D; Ljubojević M; Sekovanić A; Jurasović J; Rašić D; Peraica M; Lovrić M; Schnedler N; Henjakovic M; Wegner W; Burckhardt G; Burckhardt BC; Sabolić I
Croat Med J; 2015 Oct; 56(5):447-59. PubMed ID: 26526882
[TBL] [Abstract][Full Text] [Related]
15. Sat1 is dispensable for active oxalate secretion in mouse duodenum.
Ko N; Knauf F; Jiang Z; Markovich D; Aronson PS
Am J Physiol Cell Physiol; 2012 Jul; 303(1):C52-7. PubMed ID: 22517357
[TBL] [Abstract][Full Text] [Related]
16. SLC26A6 and NADC‑1: Future direction of nephrolithiasis and calculus‑related hypertension research (Review).
Yang X; Yao S; An J; Jin H; Wang H; Tuo B
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34458928
[TBL] [Abstract][Full Text] [Related]
17. Species differences in Cl- affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl- exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis.
Clark JS; Vandorpe DH; Chernova MN; Heneghan JF; Stewart AK; Alper SL
J Physiol; 2008 Mar; 586(5):1291-306. PubMed ID: 18174209
[TBL] [Abstract][Full Text] [Related]
18. Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.
Amin R; Asplin J; Jung D; Bashir M; Alshaikh A; Ratakonda S; Sharma S; Jeon S; Granja I; Matern D; Hassan H
Kidney Int; 2018 May; 93(5):1098-1107. PubMed ID: 29395336
[TBL] [Abstract][Full Text] [Related]
19. Oxalate transport by the mouse intestine in vitro is not affected by chronic challenges to systemic acid-base homeostasis.
Whittamore JM; Hatch M
Urolithiasis; 2019 Jun; 47(3):243-254. PubMed ID: 29947993
[TBL] [Abstract][Full Text] [Related]
20. The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man.
Whittamore JM; Hatch M
Urolithiasis; 2017 Feb; 45(1):89-108. PubMed ID: 27913853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
